MAP2K1 and hepatocellular carcinoma: Another study showed that the ANKFN1 facilitates the proliferation and metastasis of HCC cells by activating the MEK1/2-ERK1/2 signaling pathway, as evidenced by in vivo and in vitro experiments [20].